↓ Skip to main content

Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis

Overview of attention for article published in Endocrine, October 2017
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (73rd percentile)
  • Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter
2 X users
wikipedia
3 Wikipedia pages
googleplus
1 Google+ user

Citations

dimensions_citation
41 Dimensions

Readers on

mendeley
115 Mendeley
Title
Effectiveness of myoinositol for polycystic ovary syndrome: a systematic review and meta-analysis
Published in
Endocrine, October 2017
DOI 10.1007/s12020-017-1442-y
Pubmed ID
Authors

Liuting Zeng, Kailin Yang

Abstract

To assess the effectiveness and safety of myoinositol for patients with PCOS. In this meta-analysis, data from randomized controlled trials are obtained to assess the effects of myoinositol vs. placebo or western medicine in women with PCOS. The study's registration number is CRD42017064563. The primary outcomes included total testosterone, estradiol (E2) and the homeostatic model assessment (HOMA) of insulin resistance. Ten trials involving 573 patients were included. The meta-analysis results show that: compared with the control group, myoinositol may improve HOMA index (WMD -0.65; 95% CI -1.02, -0.28; P = 0. 0005) and increase the E2 level (WMD 16.16; 95% CI 2.01, 30.31; P = 0. 03); while there is no enough strong evidence that the myoinositol has an effect on the total testosterone level (WMD -16.11; 95% CI -46.08, 13.86; P = 0. 29). Based on current evidence, myoinositol may be recommended for the treatment of PCOS with insulin resistance, as well as for improving symptoms caused by decreased estrogen in PCOS.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 115 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 115 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 21 18%
Student > Postgraduate 14 12%
Student > Master 11 10%
Student > Doctoral Student 10 9%
Researcher 9 8%
Other 19 17%
Unknown 31 27%
Readers by discipline Count As %
Medicine and Dentistry 34 30%
Nursing and Health Professions 17 15%
Biochemistry, Genetics and Molecular Biology 6 5%
Agricultural and Biological Sciences 6 5%
Unspecified 5 4%
Other 15 13%
Unknown 32 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 May 2019.
All research outputs
#4,752,558
of 23,006,268 outputs
Outputs from Endocrine
#263
of 1,701 outputs
Outputs of similar age
#85,292
of 327,202 outputs
Outputs of similar age from Endocrine
#10
of 41 outputs
Altmetric has tracked 23,006,268 research outputs across all sources so far. Compared to these this one has done well and is in the 76th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,701 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.2. This one has done well, scoring higher than 82% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 327,202 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 73% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.